Integration of the PRB and P53 Cell Cycle Control Pathways

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Neuro-Oncology

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1010615822317PMID 11407592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2

  2003cited by this paper
• Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion.

  2000cited by this paper
• Reentry into the Cell Cycle of Contact-inhibited Vascular Endothelial Cells by a Phosphatase Inhibitor

  2000cited by this paper
• Subcellular Compartmentalization of E2f Family Members Is Required for Maintenance of the Postmitotic State in Terminally Differentiated Muscle

  2000cited by this paper
• INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy

  2000cited by this paper
• Identification of a Novel E2F3 Product Suggests a Mechanism for Determining Specificity of Repression by Rb Proteins

  2000cited by this paper
• Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion

  2000cited by this paper
• E2f3 is critical for normal cellular proliferation.

  2000cited by this paper
• Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

  2000cited by this paper
• p16INK4A and p19ARF act in overlapping pathways in cellular immortalization

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex

  2000cited by this paper
• Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

  2000cited by this paper
• Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.

  1999cited by this paper
• Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

  1999cited by this paper
• Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes

  1999cited by this paper
• P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.

  1999cited by this paper
• The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts

  1999cited by this paper
• Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.

  1999cited by this paper
• p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts

  1999cited by this paper
• Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

  1999cited by this paper
• p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry

  1999cited by this paper
• Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein.

  1999cited by this paper
• Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation

  1999cited by this paper
• Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

  1999cited by this paper
• E2F and Histone Deacetylase Mediate Transforming Growth Factor β Repression of cdc25A during Keratinocyte Cell Cycle Arrest

  1999cited by this paper
• Cyclin D-CDK Subunit Arrangement Is Dependent on the Availability of Competing INK4 and p21 Class Inhibitors

  1999cited by this paper
• Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity

  1999cited by this paper
• Induction of p21WAF1/CIP1and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a

  1999cited by this paper
• Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

  1999cited by this paper
• Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression.

  1999cited by this paper
• Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a

  1999cited by this paper
• Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

  1999cited by this paper
• BRCA1 signals ARF-dependent stabilization and coactivation of p53

  1999cited by this paper
• The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

  1999cited by this paper
• Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

  1999cited by this paper
• p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells

  1999cited by this paper
• RB regulates the stability and the apoptotic function of p53 via MDM2.

  1999cited by this paper
• Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth

  1998cited by this paper
• p53-Independent Role of MDM2 in TGF-β1 Resistance

  1998cited by this paper
• p130 Is Dispensable in Peripheral T Lymphocytes: Evidence for Functional Compensation by p107 and pRB

  1998cited by this paper
• Differential Expression of the p27Kip1mRNA in IFN-Sensitive and Resistant Cell Lines

  1998cited by this paper
• Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice

  1998cited by this paper
• Toward an understanding of the functional complexity of the E2F and retinoblastoma families.

  1998cited by this paper
• ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

  1998cited by this paper
• Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

  1998cited by this paper
• p53-independent role of MDM2 in TGF-beta1 resistance.

  1998cited by this paper
• Retinoblastoma protein represses transcription by recruiting a histone deacetylase

  1998cited by this paper
• Hyperphosphorylated p107 and p130 bind to T-antigen: identification of a critical regulatory sequence present in RB but not in p107/p130

  1998cited by this paper
• Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

  1998cited by this paper
• A signaling to p 53 involves the p 19 ARF tumor suppressor

  1998cited by this paper
• CDK inhibitors p18 INK4c and p27 Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis

  1998cited by this paper
• Growth Suppression by an E2F-Binding-Defective Retinoblastoma Protein (RB): Contribution from the RB C Pocket

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• Strain-Dependent Myeloid Hyperplasia, Growth Deficiency, and Accelerated Cell Cycle in Mice Lacking the Rb-Related p107 Gene

  1998cited by this paper
• E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

  1998cited by this paper
• Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d

  1998cited by this paper
• Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.

  1998cited by this paper
• E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

  1998cited by this paper
• Regulation of Mdm2-Directed Degradation by the C Terminus of p53

  1998cited by this paper
• The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53

  1998influential reference
• The regulation of E2F by pRB-family proteins.

  1998cited by this paper
• Requirement of Cyclin E-Cdk2 Inhibition in p16INK4a-Mediated Growth Suppression

  1998cited by this paper
• The complexity of p53 modulation: emerging patterns from divergent signals.

  1998cited by this paper
• E1A signaling to p53 involves the p19(ARF) tumor suppressor.

  1998cited by this paper
• CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.

  1998cited by this paper
• The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells

  1998cited by this paper
• Differential expression of the p27Kip1 mRNA in IFN-sensitive and resistant cell lines.

  1998cited by this paper
• Interaction of the pRB-family proteins with factors containing paired-like homeodomains

  1998cited by this paper
• p107 is a suppressor of retinoblastoma development in pRb-deficient mice.

  1998cited by this paper
• The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

  1998cited by this paper
• Critical Role for the 310 Helix Region of p57Kip2 in Cyclin-dependent Kinase 2 Inhibition and Growth Suppression*

  1998cited by this paper
• Rb interacts with histone deacetylase to repress transcription.

  1998cited by this paper
• Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

  1998cited by this paper
• Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

  1998cited by this paper
• Mdm2 association with p53 targets its ubiquitination

  1998cited by this paper
• p19ARF links the tumour suppressor p53 to Ras

  1998cited by this paper
• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

  1998cited by this paper
• Functional roles of E2F in cell cycle regulation

  1997cited by this paper
• Expression patterns of the E2F family of transcription factors during mouse nervous system development.

  1997cited by this paper
• Expression of G1-phase cell cycle genes during hematopoietic lineage.

  1997cited by this paper
• Cell cycle‐dependent modifications in activities of pRb‐related tumor suppressors and proliferation‐specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.

  1997cited by this paper
• Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line.

  1997cited by this paper
• E2F activity is regulated by cell cycle-dependent changes in subcellular localization

  1997cited by this paper
• Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging

  1997cited by this paper
• Concentration of RB protein in nucleus vs. cytoplasm is stable as phosphorylation of RB changes during the cell cycle and differentiation.

  1997cited by this paper
• A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts.

  1997cited by this paper
• New functional activities for the p21 family of CDK inhibitors.

  1997cited by this paper
• pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

  1997cited by this paper
• DNA damage induces phosphorylation of the amino terminus of p53.

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.

  1997influential reference
• Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper

• The Use of Intrinsic Disorder and Phosphorylation by Oncogenic Viral Proteins to Dysregulate the Host Cell Cycle Through Interaction with pRb

  2025cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Arginine starvation in colorectal carcinoma cells: Sensing, impact on translation control and cell cycle distribution.

  2016cites this paper
• Molecular Biology of Penile Cancer

  2016cites this paper
• EVALUATING THE EFFECT OF SOUTH AFRICAN HERBAL EXTRACTS ON BREAST CANCER CELLS

  2013cites this paper
• P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer

  2013cites this paper
• Investigation of the interactions of retinoblastoma binding protein-6 with transcription factors p53 and Y-Box Binding Protein-1

  2011cites this paper
• Regulatory roles of calprotectin in head and neck squamous cell carcinogenesis.

  2011cites this paper
• The RB (pRb2/p16) and p53 (p14/p53/p21) Tumor-suppressor Pathways in Endemic Burkitt Lymphoma

  2011cites this paper
• Molecular Biology of Penile Cancer

  2011cites this paper
• BURKITT LYMPHOMA IN UGANDA A study of some biological and epidemiological aspects of endemic Burkitt lymphoma

  2011cites this paper
• ON SIMULATING THE GENERATION OF MOSAICISM DURING MAMMALIAN CEREBRAL CORTICAL DEVELOPMENT

  2009cites this paper
• Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors

  2008cites this paper
• mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?

  2008cites this paper
• Do Different Disorders in Cell Cycle Regulation Account for Different Biological Behavior of Urothelial and Sinonasal Inverted Papillomas?

  2008cites this paper
• Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.

  2007cites this paper
• GENETIC ABERRATIONS IN GLIOMATOSIS CEREBRI

  2007cites this paper
• Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 5: apoptosis and cell cycle

  2005cites this paper
• Modulation of cell cycle components by epigenetic and genetic events.

  2005cites this paper
• Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma.

  2005cites this paper
• Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl‐2 expression and increased susceptibility to cisplatin‐induced apoptosis

  2004cites this paper
• Heme controls the expression of cell cycle regulators and cell growth in HeLa cells.

  2004cites this paper
• Genetic and epigenetic alterations as hallmarks of the intricate road to cancer

  2003cites this paper
• RB-resistant Abl kinase induces delayed cell cycle progression and increases susceptibility to apoptosis upon cellular stresses through interaction with p53.

  2003cites this paper
• Identification of the novel role of pRB in eye cancer

  2003cites this paper
• Mechanisms of action of the chemopreventive agent indole-3-carbinol in breast cell lines

  2003cites this paper
• Immunohistochemical Markers for Prognosis of Oligodendroglial Neoplasms

  2002cites this paper